Several other equities research analysts have also weighed in on the company. Sanford C. Bernstein set a €41.50 ($48.26) price objective on Koninklijke Philips and gave the stock a buy rating in a report on Friday, October 26th. Deutsche Bank set a €45.00 ($52.33) price objective on Koninklijke Philips and gave the company a buy rating in a research report on Friday, October 26th. HSBC set a €44.00 ($51.16) target price on Koninklijke Philips and gave the company a buy rating in a research note on Wednesday, October 24th. Morgan Stanley set a €36.00 ($41.86) price target on Koninklijke Philips and gave the stock a neutral rating in a research note on Tuesday, October 23rd. Finally, Credit Suisse Group set a €37.00 ($43.02) price target on Koninklijke Philips and gave the stock a neutral rating in a research note on Tuesday, October 23rd. Six research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company’s stock. Koninklijke Philips has a consensus rating of Buy and an average target price of €39.34 ($45.75).
Koninklijke Philips has a 52-week low of €28.92 ($33.63) and a 52-week high of €36.12 ($42.00).
Koninklijke Philips Company Profile
Koninklijke Philips N.V. is the Netherlands-based health technology company. The Company’s segments include Personal Health businesses, Diagnosis & Treatment businesses, Connected Care & Health Informatics businesses, HealthTech Other and Legacy Items. The Personal Health businesses segment is engaged in the health continuum, delivering integrated, connected solutions that support healthier lifestyles and those living with chronic disease.
Further Reading: What is Net Asset Value (NAV)?
Receive News & Ratings for Koninklijke Philips Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Koninklijke Philips and related companies with MarketBeat.com's FREE daily email newsletter.